Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific receives regulatory approval to start clinical study with its drug candidate CS1

Cereno Scientific (Aktietorget: “CRNO B”) announced today that the company has received approval from the Medical Products Agency (‘Läkemedelsverket’) and the Ethical Review Board (‘Etikprövningsnämnden’) in Uppsala, Sweden, to initiate the first clinical study of its drug candidate, CS1. The approval from the Medical Products Agency and the Ethical Review Board is the starting signal for a first clinical study with the drug candidate CS1, which Cereno Scientific has developed.The study will assess the safety and tolerability, as well as the pharmacokinetics of CS1 in adults with

Brunswick Real Estate forms Kielo, a real estate company investing in Finland, and completes its first acquisition

Helsinki, 2 October 2017 Brunswick Real Estate today announced the formation of Kielo, a real estate company aiming to acquire high quality commercial real estate in growing cities in Finland, together with its investors. Kielo has completed its first transaction acquiring a 40,000 sqm office property in Tampere from Aberdeen Standard Investment.Kielo’s investment mandate is broad and flexible, enabling the company to pursue opportunities in growing cities in Finland. The objective is to create a property portfolio in excess of EUR 1 billion over the coming years. Kielo’s investment

Enea OSE selected for 5G radio base station

Enea OSE will boost throughput and reduce latency in 5G baseband processingSTOCKHOLM, Sweden, October 2, 2017 – Enea® (Nasdaq Stockholm: ENEA), a global supplier of network software platforms and world class services, today announced that it has been selected by an Asian tier one telecom equipment manufacturer (TEM), to deliver its 64-bit Enea OSE multicore operating system for use in time-critical functions in a line of 5G radio base stations. Enea OSE was chosen based on its ability to combine high throughput with low latency on multicore processors. In the design, Enea OSE will

Q-FREE – SHARE OPTIONS GRANTS

Q-Free ASA has granted a total of 1 392 053 share options to the following primary insiders, in accordance with the incentive program for leading executives adopted by the General Meeting 24 May 2017. Tor Eirik Knutsen, CFO, has been granted 258 216 share options with a strike price of NOK 8.52, 184 440 share options with a strike price of NOK 11.93, and 151 892 share options with a strike price of NOK 14.48. Knutsen has no shares in Q-Free ASA. Fredrik Nordh, SVP Europe, has been granted 228 991 share options with a strike price of NOK 8.52, 163 565 share options with a strike price

Professor Fredrik Höök purchases an Acoulyte instrument and becomes reference center for Insplorion within bio applications

Fredrik Höök, professor in Biological Physics at the Department of Physics, Chalmers University of Technology, becomes a customer to Insplorion and an Acoulyte user within a reference center collaboration. Prof. Höök and his group are leading researchers in drug delivery systems and molecular interactions with cell surfaces. Höök is also one of the founders of Q-Sense and is an expert on the acoustic QCM-D technology that Insplorion's optical NPS technology is combined with using the Acoulyte instrument. The solid knowledge in both life science and QCM-D makes Fredrik Höök's group a very

Victoria Park’s Nomination Committee ahead of 2018 AGM appointed

According to a motion passed at the 2017 Annual General Meeting (AGM) of Victoria Park AB shareholders, the four largest shareholders in terms of voting power are to be invited to appoint members of the Nomination Committee ahead of the 2018 AGM. Those who are appointed by these shareholders, together with the Chairman of the Board as the convener, shall constitute the company’s Nomination Committee. Ahead of the 2018 AGM, Victoria Park’s Nomination Committee consists of Greg Dingizian and Anders Pettersson, based on their own mandate, Gillis Cullin based on the mandate of the Foundation

Medals of War featured by Apple

Nitro Games’ latest game “Medals of War” is currently featured by Apple on App Store.Medals of War is currently featured by Apple in the ”New Games We Love” -category on the front page of the App Store in 18 countries, including United States. "We’re delighted to get this visibility for Medals of War from Apple. This is our first big self-published game and that makes us feel proud of this recognition. We see this as yet another validation that we’re on the right path with our MVP process and with Medals of War.”  says Jussi Tähtinen, CEO and Co-Founder, Nitro Games Oyj. Medals of War

Atlas Copco wins orders in Kazakhstan for highly productive mining operations

Stockholm, Sweden, October 2, 2017: Atlas Copco, a leading provider of sustainable productivity solutions, has won recent orders from Kazakhmys Corporation, a leading copper producer in Kazakhstan. The mining equipment will enhance the customer’s productivity, safety and ergonomics.The orders include dozens of mine trucks, loaders and drilling rigs for use in 11 mines, including the major Zhomart copper and silver mine in Central Kazakhstan. The orders total MEUR 22.5 (MSEK 215) and were received in the second and third quarters of 2017.  Equipment delivery has started and will continue

Rörgruppen to carry out heating and plumbing installations in NCC’s new head office

Instalco’s subsidiary Rörgruppen has been awarded a contract to carry out heating and plumbing installations in NCC’s new head office in Solna. The order value amounts to approximately SEK 50 million.The head office will be built in Järva Krog, Solna, and represents the start of a major development of the area, where three new city blocks with offices, restaurants, service and residential properties are planned. The building where NCC's head office will be located consists of approximately 20,000 square meters of leasable area and is expected to be completed in 2019. “We are happy and

Selvaag Bolig ASA: invitation to capital markets update

Selvaag Bolig ASA is pleased to invite investors, analysts, media and other stakeholders to a capital markets update on Thursday 9 November 2017 in Oslo. We will provide an update on our strategy and financial development, and discuss the market and company outlook. Our third-quarter results will be released on the same day and presented at the event. Presentations will be given by CEO Baard Schumann, CFO Sverre Molvik and Nejra Macic from Prognosesenteret, an independent market analysis company which specialises in the Nordic construction and property markets. Directors of our

Orexo signs asset purchase agreement with Gesynta Pharma AB for OX-MPI

Uppsala, Sweden – October 2, 2017 – Orexo AB (publ.) today announced that Orexo has signed an asset purchase agreement with Gesynta Pharma AB – a recently formed research company located in Stockholm, Sweden. Among the founders are highly reputed executives from the biotech industry and experienced researchers at the Karolinska Institute within the field of arachidonic acid pathways and inflammatory diseases. The lead candidate drug in the OX-MPI program, BI1029539, has been identified as a highly selective anti-inflammatory compound targeting microsomal prostaglandin E synthase (mPGES-1).

The combined Intrum Justitia and Lindorff becomes Intrum

On June 27th 2017, the combination of Intrum Justitia and Lindorff was completed, creating the leading provider of credit management services (CMS). Today, the company takes an important step towards consolidating the two companies by introducing a new corporate identity and brand name. ”Intrum is the undisputed market leader. This presents new opportunities for growth through joined resources, broader geographical presence and increased financial strengths to be able to make investments to secure long term added value for all our stakeholders. To best make use of these opportunities we

Phase I extension study demonstrates beneficial effects on lipid metabolism with C21

Vicore Pharma AB (publ) (ticker: VICO) can today announce positive results from the in-depth analysis of the Phase I extension study with its candidate drug named C21.The extension study, initiated in January 2017, was performed on a group of overweight (BMI 30-35 and waist-to-hip ratio (WHR) above 0.9) but otherwise healthy men. In total 16 volunteers participated, whereof 8 were given 100 mg C21 in a once daily dose and 8 were given placebo over a period of 8 days. The aim of the study was to evaluate safety and tolerability of C21 in a group with a potentially compromised metabolic

KappAhl launches "Click & Collect" and "Shop Online in Store"

At the turn of the month, KappAhl took the next big step on its journey to digitisation, launching Click&Collect and Shop Online in Store.     “Every way of shopping at KappAhl should be integrated. Online and physical stores aren’t different channels; they’re two parts of the same KappAhl. The customer chooses, we deliver. Because there is always stock online, this means that items are never sold out in stores, either,” says Charlotte Katz, Head of Digital at KappAhl.KappAhl is now launching Click&Collect and Shop Online in Store on a wide scale. Sweden was first up in the rollout, soon

Elekta and The Alliance for Cancer Care partner to bring leading-edge radiation therapy and radiosurgery solutions to patients

The Alliance for Cancer Care converts all oncology treatment devices and software to Elekta products, improving and standardizing care across its multiple sitesSTOCKHOLM, October 2, 2017 – Elekta (EKTA-B.ST) today announced that the Alliance for Cancer Care (The Alliance) is adopting Elekta products and services as the complete solution for its radiation oncology needs. With this adoption, Elekta hardware and software will replace all other radiation therapy products and services at The Alliance’s seven radiation therapy facilities. Established in 2015, The Alliance brings together the

SSM acquires housing project for approximately 370 homes in central Jakobsberg

SSM Holding AB (publ), the leading property developer in the Stockholm region within affordable homes, is continuing to expand by acquiring a housing project in central Jakobsberg from Upland Securities AB. The project comprises a total floor space of approximately 19,000 m2 that SSM intends to develop into about 370 cooperative apartments. The initial purchase price is 30 MSEK plus an additional sum once the detailed development plan has been approved. The sales start is expected in the second quarter of 2018, with occupancy to start in the beginning of 2020.SSM has acquired a property (

Orkla ASA: Key information relating to the cash dividend

At a meeting on 2 October 2017, the Board of Directors decided to call for an extraordinary general meeting in order to propose a special dividend of NOK 5.00 per share.   Dividend amount: 5.00 per share Declared currency: NOK Last day including right: 25 October 2017 Ex-date: 26 October 2017 Record date: 27 October 2017 Payment date: 3 November 2017 Date of approval: 25 October 2017   Orkla ASA Oslo, 2 October 2017     Ref.:   SVP Investor Relations Mattias Orrenius  Tel.: +47 983 66 334 Email: mattias.orrenius@orkla.no   Group

Orkla ASA: Agreement regarding sale of Orkla's interest in Sapa to Hydro completed

Reference is made to the stock exchange notice of 10 July 2017 regarding announcement of an agreement between Orkla and Norsk Hydro ("Hydro") whereby Hydro is to purchase Orkla's 50% interest in Sapa. The agreement was completed today in accordance with its terms.   Orkla has today received NOK 11.86 billion in cash from Hydro as preliminary purchase price, which represent a valuation of Sapa of NOK 27 billion (on debt-free basis). Final purchase price will be determined based on Sapa's balance as of 30 September 2017.   Orkla has been a shareholder in Sapa since 2005. When Sapa

Multiconsult ASA – Repurchase of own shares

On 29 September 2017, Multiconsult ASA ("Multiconsult") purchased 1 045 of its own shares at an average price of NOK 87.68 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 24 201 of its own shares.    For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

Selvaag Bolig ASA: Quieter market, but good sales

Selvaag Bolig ASA sold 207 homes with a total value of NOK 843 million during the third quarter of 2017. Sales in the first nine months totalled 632 homes worth NOK 2 867 million in all. "The market has been quieter than in earlier periods. This primarily reflects the residential mortgage and the market psychology. However, sales have been good in many of our projects," says CEO Baard Schumann.Construction started for 77 units during the quarter, 81 were completed and 75 were delivered to the buyer. At 30 September, Selvaag Bolig had 1 582 homes under construction and 30 completed

New Zealand Navy Chooses Saab TactiCall for Future Communications Solution

Defence and security company Saab has signed a contract to provide a complete communications system on board the Royal New Zealand Navy’s future fleet replenishment vessel, HMNZS Aotearoa.The Royal New Zealand Navy (RNZN) has selected Saab to equip its new Maritime Sustainment Capability vessel, HMNZS Aotearoa. Saab will provide the TactiCall integrated communications system, which interconnects communication technologies regardless of radio band, frequency or hardware. Electronic Navigation Ltd (ENL) will provide in-service support as Saab’s partner in New Zealand. -       This is our

Nordea and DNB have completed the combination of their Baltic operations

On 25 August 2016 Nordea and DNB entered into an agreement to combine their operations in Estonia, Latvia and Lithuania in order to create a leading independent main financial services provider in the Baltics. The completion was conditional upon receiving regulatory approvals and conditions. After receiving all approvals from the respective regulatory bodies, the transaction closed today. Luminor will be the third largest financial services provider in the Baltic banking market with a market share of 16 per cent in deposits and 23 per cent in lending. Luminor will comprise Nordea’s

Promising preliminary long-term data from WTX101 Phase 2 extension study to be presented at AASLD Annual Meeting

Wilson Therapeutics (publ) announced today that preliminary data from the ongoing extension part of the Phase 2 trial of WTX101 (bis-choline tetrathiomolybdate), an investigational oral first-in-class copper-protein binding agent for the treatment of patients with Wilson Disease, have been accepted for poster presentation at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Washington DC, October 20-24, 2017. The abstract, published online today, highlights that the initial improvements seen after 24 weeks were continued. Free

There are no items matching the current filter
There are no more items matching the current filter
Back to top